An update on lipid-based nanodrug delivery systems for leishmaniasis treatment-Reference-Cited by-同舟云学术

An update on lipid-based nanodrug delivery systems for leishmaniasis treatment

Published:2023-09 Issue:21 Volume:18 Page:1417-1419
ISSN:1743-5889
Container-title:Nanomedicine
language:en
Short-container-title:Nanomedicine

Author:

Mishra Vaishali Sunil¹^ORCID,Tiwari Preeti²^ORCID,Gupta Madhu³^ORCID,Gupta Piyush Kumar¹⁴^ORCID

Affiliation:

1. Department of Life Sciences, Sharda School of Basic Sciences & Research, Sharda University, Greater Noida, Uttar Pradesh, 201310, India

2. Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi, 110025, India

3. School of Pharmaceutical Sciences, Department of Pharmaceutics, Delhi Pharmaceutical Sciences & Research University, Pushp Vihar, Sector 3, MB Road, New Delhi, 110017, India

4. Department of Biotechnology, Graphic Era Deemed to Be University, Dehradun, Uttarakhand, 248002, India

Abstract

Lipid-based nanodrug delivery systems hold considerable promise in therapeutic intervention for leishmaniasis by enhancing drug solubility and targeted delivery.

Funder

Science and Engineering Research Board

Publisher

Future Medicine Ltd

Subject

Development,General Materials Science,Biomedical Engineering,Medicine (miscellaneous),Bioengineering

Link

https://www.futuremedicine.com/doi/pdf/10.2217/nnm-2023-0190

Reference15 articles.

1. Nanoparticles for the treatment of visceral leishmaniasis: review

2. Lipid based nanocarriers: a translational perspective

3. Evaluation of the Efficacy of Amphotericin B and Terbinafine Microemulsions and Their Combination on Cutaneous Leishmaniasis and Comparison with the Conventional Drug Form in BALB/c Mice

4. Nanotechnology-aided diagnosis, treatment and prevention of leishmaniasis

5. A new medium-throughput screening design approach for the development of hydroxymethylnitrofurazone (NFOH) nanostructured lipid carrier for treating leishmaniasis